Most Recent
Construction PRO
National Storage REIT receives $4B takeover offer from Brookfield consortium
A consortium of Brookfield Property and GIC Investments has moved to acquire National Storage REIT, making an offer that values the self-storage investor at $4 billion.
Treasurer blocks Cosette’s $672M takeover of Mayne Pharma
Treasurer Jim Chalmers has blocked Cosette's $672 million takeover of Mayne Pharma on national interest grounds after the US drug maker threatened to close a critical drug facility in Adelaide.
Construction PRO
Qube receives $11.6B takeover offer from Macquarie
Macquarie Asset Management has made an offer to acquire Qube which values the infrastructure giant at $11.6 billion.
Construction PRO
MA Financial seals $679M deal to buy Hyperdome Town Centre from QIC
MA Financial Group has added Hyperdome Town Centre to its real estate portfolio, acquiring the South-East Queensland shopping complex from QIC for $678.7 million.
Takeovers Panel says Cosette can’t shutter Mayne’s Adelaide drug plant
The Takeovers Panel has found Cosette cannot close a Mayne Pharma drug manufacturing plant in Adelaide, another win for Mayne in its push to block the US drug maker from walking away from their $672 million merger.
Mayne wins extension of FIRB deadline for Cosette takeover
The Foreign Investment Review Board has extended the deadline for ruling on Cosette's proposed $672 million takeover of Mayne Pharma.
Construction PRO
Link REIT bids for three Lendlease shopping centres
Hong Kong-based Link REIT has made a play to acquire three of five Lendlease shopping centre assets that comprise a $2.9 billion property fund that are being sold down amid a slew of redemption requests.
Ashurst to merge with US firm Perkins Coie
Ashurst has announced plans to merge with US law firm Perkins Coie, creating a powerhouse firm with 3,000 lawyers across 23 countries with ambitions to lead the way on AI.
Mayne, Cosette row to be decided on merits after panel resets merger clock
The Takeovers Panel has agreed to hear Mayne Pharma's latest dispute with Cosette over the US drug maker's attempts to walk away from their $672 million merger agreement and extended the timeline for completing the deal.
Mayne wins breathing room in fight to get Cosette merger over the line
Mayne Pharma has secured an extension of the deadline for securing Foreign Investment Review Board approval of its $672 million tie-up with US drug maker Cosette.